NASDAQ | ETF
Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from products or services related to GLP-1 and the treatment of cardiovascular diseases and/or metabolic diseases, as defined by the Centers for Diseases Control and Preventions.
The fund generally is expected to consist of more than 15 companies but not more than 100 companies.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 9.86% |
| ABT | Abbott Laboratories | Healthcare | Medical Devices | 4.61% |
| AZN | AstraZeneca PLC | Healthcare | Drug Manufacturers - General | 4.13% |
| 0QIU | Novo Nordisk A/S Class B | 4.06% | ||
| NOVO-B | Novo Nordisk A/S | Healthcare | Biotechnology | 3.94% |
| UNH | UnitedHealth Group Incorporated | Healthcare | Healthcare Plans | 3.89% |
| RHHBY | Roche Holding Ltd ADR | Healthcare | Drug Manufacturers - General | 3.86% |
| BSX | Boston Scientific Corp | Healthcare | Medical Devices | 3.36% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 3.22% |
| BBIO | BridgeBio Pharma Inc | Healthcare | Biotechnology | 3.14% |
| MDT | Medtronic PLC | Healthcare | Medical Devices | 3.11% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 3.03% |
| NOVN | Novartis AG | Healthcare | Drug Manufacturers - General | 3.03% |
| CRNX | Crinetics Pharmaceuticals Inc | Healthcare | Biotechnology | 2.87% |
| TMO | Thermo Fisher Scientific Inc | Healthcare | Diagnostics & Research | 2.84% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 2.48% |
| 4519 | Chugai Pharmaceutical Co. Ltd. | Healthcare | Drug Manufacturers - General | 2.44% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 2.35% |
| PODD | Insulet Corporation | Healthcare | Medical Devices | 2.33% |
| EW | Edwards Lifesciences Corp | Healthcare | Medical Devices | 2.24% |